William Blair downgraded Kinnate Biopharma (KNTE) to Market Perform from Outperform after Kinnate announced an agreement to be acquired by Xoma Corporation (XOMA).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KNTE:
